Consistent prolonged "concordant" survival of hamster-to-rat cardiac xenografts by inhibition of anti-species antibodies with methotrexate.
Hasan
R I
RI
Department of Surgery, Addenbrookes Hospital, Cambridge, United Kingdom.
Sriwatanawongsa
V
V
Wallwork
J
J
White
D J
DJ
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000096:biosynthesis; D000917:Antibody Formation / Q000187:drug effects; D006224:Cricetinae; D003520:Cyclophosphamide / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000276:immunology; D006085:Graft Survival / Q000276:immunology*; D016027:Heart Transplantation / Q000276:immunology*; D007165:Immunosuppression Therapy / Q000379:methods; D008647:Mesocricetus; D008727:Methotrexate / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains; D014183:Transplantation, Heterologous / Q000276:immunology*; D016042:Transplantation, Heterotopic
D000888:Antibodies, Anti-Idiotypic; D016572:Cyclosporine; D003520:Cyclophosphamide; D008727:Methotrexate